Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8a51b30b602ef94a7879fc2a38e5fdd2 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7076 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7076 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-44 |
filingDate |
2006-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_428bd6b85a98ef8b4b9aa5e8d17bb715 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6ac850cd513698d2b1a2a4a41699dc7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b66b1db89799a217221e82004c6366fe |
publicationDate |
2006-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2006247200-A1 |
titleOfInvention |
Methods and uses of leukotriene B4 hydroxylases to treat diseases |
abstract |
Methods and uses are described for treating or preventing diseases of humans or non-human animals by reducing the amount of active leukotriene B 4 (LTB 4 ) in those in need of such treatment using LTB 4 hydroxylases. In certain embodiments, LTB 4 hydroxylase is administered in combination with nicotinamide adenine dinucleotide phosphate and/or an NADPH-cytochrome P-450 reductase. The invention is particularly useful for treating or preventing respiratory diseases that are caused or exacerbated by inflammation. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110200985-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020244508-A1 |
priorityDate |
2005-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |